A58677300074696275 RLS

PROCESSED AT :
Thyrocare,Sohrabh Hall,
112, A Wing, 1st Floor,
Sangamwadi, Pune – 411 001
NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

REF. BY 765 AMRUTESHWARI NILAYAM SHREE COLONY
: SELF
CHS NEAR LIONS CLUB SCHOOL MAMURDI DEHU
TEST ASKED : PSA,SENIOR CITIZEN PACKAGE FOR 2 ROAD PUNE 412101
PATIENTID : MN21239430
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 6.9 %
Reference Range :
Reference Range: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 151 mg/dl
Reference Range :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 07 Mar 2023 07:26
Sample Received on (SRT) : 07 Mar 2023 15:13

Report Released on (RRT) : 07 Mar 2023 17:40
Sample Type : EDTA
Labcode : 0703085863/PP004 Dr Keerthi K MD(Path)
Barcode : AR346471
Page : 1 of 20
PROCESSED AT :

REF. BY : SELF 765 AMRUTESHWARI NILAYAM SHREE COLONY
CHS NEAR LIONS CLUB SCHOOL MAMURDI
TEST ASKED : PSA,SENIOR CITIZEN PACKAGE FOR 2
DEHU ROAD PUNE 412101
TEST NAME VALUE UNITS REFERENCE RANGE
TOTAL LEUCOCYTES COUNT (WBC) 6.64 X 10³ / µL 4.0-10.0
NEUTROPHILS 68 % 40-80
LYMPHOCYTE PERCENTAGE 25.6 % 20-40
MONOCYTES 3.2 % 0-10
EOSINOPHILS 2.4 % 0.0-6.0
BASOPHILS 0.5 % <2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT 4.51 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 1.7 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.21 X 10³ / µL 0.2-1
BASOPHILS - ABSOLUTE COUNT 0.03 X 10³ / µL 0-0.1
EOSINOPHILS - ABSOLUTE COUNT 0.16 X 10³ / µL 0-0.5
IMMATURE GRANULOCYTES(IG) 0.03 X 10³ / µL 0-0.3
TOTAL RBC 5.4 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS Nil X 10³ / µL <0.01
NUCLEATED RED BLOOD CELLS % Nil % <0.01
HEMOGLOBIN 14.3 g/dL 13-17
HEMATOCRIT(PCV) 46.2 % 40-50
MEAN CORPUSCULAR VOLUME(MCV) 85.6 fL 83-101
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 26.5 pq 27-32
MEAN CORP.HEMO.CONC(MCHC) 31 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 42.1 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) 13.6 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) 13.2 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 10.6 fL 6.5-12
PLATELET COUNT 254 X 10³ / µL 150-400
PLATELET TO LARGE CELL RATIO(PLCR) 30.8 % 19.7-42.4
PLATELETCRIT(PCT) 0.27 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.
Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method
(using a semiconductor laser), and SLS- hemoglobin method)

Sample Type : EDTA
Labcode : 0703085863/PP004 Dr Keerthi K MD(Path)
Barcode : AR346471 Page : 2 of 20
PROCESSED AT :

REF. BY : SELF 765 AMRUTESHWARI NILAYAM SHREE COLONY CHS
NEAR LIONS CLUB SCHOOL MAMURDI DEHU ROAD
TEST ASKED : PSA,SENIOR CITIZEN PACKAGE FOR 2 PUNE 412101
FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 153.5 mg/dL
Reference Range :-
As per ADA Guideline: Fasting Plasma Glucose (FPG)
Normal 70 to 100 mg/dl
Prediabetes 100 mg/dl to 125 mg/dl
Diabetes 126 mg/dl or higher
Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Method:- GOD-PAP METHOD

Sample Type : FLUORIDE
Dr Keerthi K MD(Path)
Labcode : 0703084011/PP004
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

: SELF
25-OH VITAMIN D (TOTAL) C.L.I.A 32.39 ng/ml

Reference Range :
DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml
Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical
for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic
syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.
Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.
Method : FULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY
VITAMIN B-12 C.L.I.A 462 pg/ml
Reference Range :
Normal : 211 - 911 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.
Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml
Kit Validation reference:

Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby;
1987:569–73.
Method : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Labcode : 0703097416/PP004 Dr Kuldeep Singh MD(Path) Dr Sachin Patil MD(Path)
Barcode : AR896940
Page : 4 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

: SELF
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 137 mg/dL

Reference Range :
Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 114 mg/dL
Reference Range :
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.8 Ratio
Reference Range :
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : DERIVED FROM SERUM APO A1 AND APO B VALUES

Sample Type : SERUM
Barcode : AR896940
Page : 5 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 2 mg/L
Reference Range :-
< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation
Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as infection ,
active arthritis or concurrent illness.
Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk for
future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP tests, ideally
taken two weeks apart.
Kit Validation Reference:

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Type : SERUM
Dr Kuldeep Singh MD(Path) Dr Sachin Patil MD(Path)
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

: SELF
IRON PHOTOMETRY 122.2 µg/dl

Reference Range :
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 377.7 µg/dl
Reference Range :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 32.35 %
Reference Range :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES
FERRITIN C.M.I.A 81.2 ng/ml
Reference Range :
Men: 21.81 - 274.66 ng/ml
Women: 4.63 - 204.00 ng/ml
Method : Fully Automated Chemi Luminescent Microparticle Immunoassay
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 255.5 µg/dl
Reference Range :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY

Sample Type : SERUM
Barcode : AR896940
Page : 7 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

Lipoprotein (a) [Lp(a)] IMMUNOTURBIDIMETRY 35.3 mg/dl
Reference Range :-
Adults : < 30.0 mg/dl
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for diagnostic
purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings.
Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %
Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

SERUM COPPER PHOTOMETRY 108.23 µg/dL
Reference Range :-
Male : 63.5 - 150

Female : 80 - 155
Clinical significance:
Copper is an important trace element and a component of numerous enzymes and proteins involved in energy production, connective
tissue formation, melanin synthesis, iron metabolism, development of central nervous system, angiogenesis as well as an antioxidant.
Deficiency can cause- Malnourishment, cardiovascular disease, anemia & neuropathy, toxicity may be manifested as acute renal failure,
gastroenteritis & chronic liver disease.
Specifications:
Precision: Intra assay (%CV): 1.17, Inter assay (%CV): 2.32.
Kit validation references:

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 337-8

Method:- 3,5-DIBR-PAESA

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

SERUM ZINC PHOTOMETRY 75.75 µg/dL
Reference Range :-
52 - 286
Zinc is one of the essential trace elements in the body. Its metalloenzymes play a key rple in protein and nucleic acid synthesis, gene
expression, wound healing, as an antioxidant, etc. Deficiency can cause- Poor wound healing, gastroenteritis, impaired
spermatogenesis, Alzheimer’s disease, etc. Toxicity may be manifested as pancreatitis, gastric ulcer, anemia, pulmonary fibrosis.
Specifications:
Precision: Intra assay (%CV): 2.02, Inter assay (%CV): 2.22.
Kit Validation References:

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 347-9

Method:- NITRO - PAPS

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

PROSTATE SPECIFIC ANTIGEN (PSA) C.L.I.A 0.87 ng/ml
Reference Range :-
Normal : < 4.00 ng/ml

Border line : 4.01 to 10.00 ng/ml
Elevated levels of PSA are associated with prostate cancer, but may also be seen with prostatitis (Inflammation of the prostate) and
benign prostatic hyperplasia (BPH). PSA test done along with free PSA provides additional information. Studies have suggested that the
percentage of free PSA in total PSA is lower in patients with prostate cancer than those with benign prostate hyperplasia.
Specification:
Precision: Intra assay (%CV): 4.38%, Inter assay (%CV): 4.67%; Sensitivity: 0.01 ng/ml
Kit validation references:
Wang MC, Valenzuala LA, Murphy GP, and Chu TM. Purification of a human prostate-specific antigen. Invest. Urol. 1979; 17: 159

Method:- TWO SITE SANDWICH IMMUNOASSAY

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

AMYLASE PHOTOMETRY 74.8 U/L
Reference Range :-
Adults : 28-100 U/L
Interpretation:
Lipemic Sera (Hypertriglyceridemia) may contain inhibitors, Which falsely depress results. About 20% of patients with Acute
Pancreatitis have abnormal lipids. Normal serum amylase may occur in Pancreatitis, Especially relapsing and chronic pancreatitis.
Moderate increases may be reported in normal pregnancy.
Causes of high Serum Amylase include Acute Pancreatitis, Pancreatic Pseudocyst, Pancreatic Ascites, Pancreatic Abscess, Neoplasm in
or adjacent to Pancreas, Trauma to Pancreas, and common Duct Stones. Nonpancreatic Causes include inflammatory salivary lesions
(Eg, Mumps), Perforated Peptic Ulcer, Intestinal Obstruction, Biliary Tract Disease, Peritonitis, Acute Appendicitis, Diabetic
Ketoacidosis, and Extrapancreatic Carcinomas. Amylase levels more than 25-fold the upper limit of normal are often found when
metastatic tumors produce Ectopic Amylase.
Specifications:
Precision: Intra assay (%CV): 2.82, Inter assay (%CV): 2.49, Sensitivity: 10.9 U/L.

Rauscher, E., et coll., Fresenius Z. Analyt. Chem. 324 (1986) 304-305.

Method:- ENZYMATIC COLORIMETRIC TEST

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

LIPASE PHOTOMETRY 37.4 U/L
Reference Range :-
Adults : 5.6 - 51.3 U/L
Interpretation:
For diagnostic purposes, the results should always be assessed in conjunction with the patient’s medical history, clinical examination
and other findings like serum amylase. Serum Lipase is usually normal in patients with elevated serum amylase, having peptic ulcer,
salivary adenitis, inflammatory bowel disease, intestinal obstruction, and macroamylasemia. Lipemic sera may interfere with results.
High serum Lipase is a specific marker for pancreatitis; after acute pancreatitis the Lipase activity increases within 4-8 hours, reaches
a peak after 24 hours and decreases after 8 to 14 days. However, there is no correlation between the Lipase activity determined in
serum and the extent of damage to the pancreas.
Specifications:
Precision: Intra assay (%CV): 3.35, Inter assay (%CV): 2.46, Sensitivity: 3.5 U/L.

Tietz Nw Et Al. Lipase In Serum - The Elusive Enzyme: An Overview. Clin Chem 1993; 39:746-756.

Method:- ENZYMATIC COLORIMETRIC ASSAY

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

REF. BY 765 AMRUTESHWARI NILAYAM SHREE COLONY CHS NEAR
: SELF
LIONS CLUB SCHOOL MAMURDI DEHU ROAD PUNE
TEST ASKED : PSA,SENIOR CITIZEN PACKAGE FOR 2 412101
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
TOTAL CHOLESTEROL PHOTOMETRY 224 mg/dl < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 49 mg/dl 40-60
HDL / LDL RATIO CALCULATED 0.31 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 160 mg/dl < 100
TRIG / HDL RATIO CALCULATED 1.64 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 80 mg/dl < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.6 Ratio 3-5
LDL / HDL RATIO CALCULATED 3.3 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 16.06 mg/dl 5 - 40
NON-HDL CHOLESTEROL CALCULATED 175.1 mg/dl < 160
Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
HD/LD - Derived from HDL and LDL values.
LDL - DIRECT MEASURE
TRI/H - Derived from TRIG and HDL Values
TRIG - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

: SELF
ALKALINE PHOSPHATASE PHOTOMETRY 87.2 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.61 mg/dl 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.13 mg/dl < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.48 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 36.5 U/l < 55
SGOT / SGPT RATIO CALCULATED 0.97 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 26.9 U/l < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.6 U/l < 45
PROTEIN - TOTAL PHOTOMETRY 7.17 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.38 gm/dl 3.2-4.8
SERUM GLOBULIN CALCULATED 2.79 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.57 Ratio 0.9 - 2
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

: SELF
UREA (CALCULATED) CALCULATED 35.89 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 16.77 mg/dL 7.04-20.07
UREA / SR.CREATININE RATIO CALCULATED 46.61 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.77 mg/dl 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 21.78 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 9.61 mg/dl 8.8-10.6
URIC ACID PHOTOMETRY 5.82 mg/dl 4.2 - 7.3
SODIUM I.S.E 137.51 mmol/l 136 - 145
CHLORIDE I.S.E 101.59 mmol/l 98 - 107
Method :
UREAC - Derived from BUN Value.
BUN - KINETIC UV ASSAY.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

765 AMRUTESHWARI NILAYAM SHREE COLONY CHS NEAR
REF. BY : SELF
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 126 ng/dl 60-200
TOTAL THYROXINE (T4) C.L.I.A 9.3 µg/dl 4.5-12
THYROID STIMULATING HORMONE (TSH) C.L.I.A 4.75 µIU/ml 0.3-5.5
Comments : SUGGESTING THYRONORMALCY
Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
TSH - Sandwich Chemi Luminescent Immuno Assay
Disclaimer :
Results should always be interpreted using the reference range provided by the laboratory that performed the test.
Different laboratories do tests using different technologies, methods and using different reagents which may cause difference
In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports.
To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory.

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 95 mL/min/1.73 m2
Reference Range :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the
doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining.
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009;150(9):604-12.

Method:- CKD-EPI Creatinine Equation

Sample Type : SERUM
Labcode : 0703097416/PP004
PROCESSED AT :

765 AMRUTESHWARI NILAYAM SHREE COLONY
REF. BY : SELF
TEST NAME OBSERVATION UNITS REFERENCE RANGE
Complete Urinogram
Physical Examination
VOLUME 3 mL -
COLOUR PALE YELLOW - Pale Yellow
APPEARANCE CLEAR - Clear
SPECIFIC GRAVITY < 1.003 - 1.003-1.030
PH 6 - 5-8
Chemical Examination
URINARY PROTEIN ABSENT mg/dl Absent
URINARY GLUCOSE ABSENT mg/dl Absent
URINE KETONE ABSENT mg/dl Absent
URINARY BILIRUBIN ABSENT mg/dl Absent
UROBILINOGEN < 0.2 mg/dl <=0.2
BILE SALT ABSENT - Absent
BILE PIGMENT ABSENT - Absent
URINE BLOOD ABSENT - Absent
NITRITE ABSENT - Absent
MICROALBUMIN 10 mg/l < 30
Microscopic Examination
MUCUS ABSENT - Absent
RED BLOOD CELLS ABSENT Cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) ABSENT Cells/HPF 0-5
EPITHELIAL CELLS 1-2 Cells/HPF 0-5
CASTS ABSENT - Absent
CRYSTALS ABSENT - Absent
BACTERIA ABSENT - Absent
YEAST ABSENT - Absent
PARASITE ABSENT - Absent
Method : Fully Automated DIRUI H-100 Urinalysis Dipstick Method, Microscopy
~~ End of report ~~

Sample Type : URINE
Dr Keerthi K MD(Path)
Labcode : 0703084879/PP004
Barcode : AT658400 Page : 19 of 20
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 20 of 20

A58677300074696275 RLS

Uploaded by

Copyright:

Available Formats

A58677300074696275 RLS

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

A58677300074696275 RLS

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Reference Range: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 07 Mar 2023 07:26

Sample Received on (SRT) : 07 Mar 2023 15:13

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Please Correlate with clinical conditions.

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

25-OH VITAMIN D (TOTAL) C.L.I.A 32.39 ng/ml

Normal : 211 - 911 pg/ml

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

Kit Validation reference:

Sample Collected on (SCT) : 07 Mar 2023 07:26

Sample Received on (SRT) : 07 Mar 2023 19:29

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 137 mg/dL

Sample Collected on (SCT) : 07 Mar 2023 07:26

Sample Received on (SRT) : 07 Mar 2023 19:29

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

< 1.00 - Low Risk

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

IRON PHOTOMETRY 122.2 µg/dl

Sample Collected on (SCT) : 07 Mar 2023 07:26

Sample Received on (SRT) : 07 Mar 2023 19:29

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Adults : < 30.0 mg/dl

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Male : 63.5 - 150

Kit validation references:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Kit Validation References:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Normal : < 4.00 ng/ml

Kit validation references:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 07 Mar 2023 07:26

NAME : MURLIDHAR NAIDU(66Y/M) HOME COLLECTION :

Adults : 28-100 U/L

Kit Validation References:

Please correlate with clinical conditions.